Items where authors include "Lambe, T"

Article

Tomic, A, Skelly, DT, Ogbe, A et al. (105 more authors) (2022) Divergent trajectories of antiviral memory after SARS-CoV-2 infection. Nature Communications, 13 (1). 1251. ISSN 2041-1723

Dejnirattisai, W, Huo, J, Zhou, D et al. (461 more authors) (2022) SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses. Cell, 185 (3). 467-484.e15. ISSN 0092-8674

Swanson, PA, Padilla, M, Hoyland, W et al. (67 more authors) (2021) AZD1222/ChAdOx1 nCoV-19 vaccination induces a polyfunctional spike protein-specific Th1 response with a diverse TCR repertoire. Science Translational Medicine, 13 (620). eabj7211. ISSN 1946-6234

Flaxman, A, Marchevsky, NG, Jenkin, D et al. (184 more authors) (2021) Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002). The Lancet, 398 (10304). pp. 981-990. ISSN 0140-6736

Swanson, PA, Padilla, M, Hoyland, W et al. (63 more authors) (2021) T-cell mediated immunity after AZD1222 vaccination : a polyfunctional spike-specific Th1 response with a diverse TCR repertoire. medRxiv. (Submitted)

Emary, KRW, Golubchik, T, Aley, PK et al. (64 more authors) (2021) Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7) : an exploratory analysis of a randomised controlled trial. The Lancet, 397 (10282). pp. 1351-1362. ISSN 0140-6736

Ogbe, A, Kronsteiner, B, Skelly, DT et al. (77 more authors) (2021) T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses. Nature Communications, 12 (1). 2055.

Voysey, M, Costa Clemens, SA, Madhi, SA et al. (763 more authors) (2021) Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials. The Lancet, 397 (10277). pp. 881-891. ISSN 0140-6736

Voysey, M, Clemens, SAC, Madhi, SA et al. (80 more authors) (2020) Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. The Lancet, 397 (10269). pp. 99-111. ISSN 0140-6736

Alharbi, NK, Padron-Regalado, E, Thompson, CP et al. (10 more authors) (2017) ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice. Vaccine, 35 (30). pp. 3780-3788. ISSN 0264-410X